Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 25;26(7):1843.
doi: 10.3390/molecules26071843.

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review

Marilyn Hagan  1 , Bu' Hussain Hayee  2 , Ana Rodriguez-Mateos  3
Affiliations
Review

(Poly)phenols in Inflammatory Bowel Disease and Irritable Bowel Syndrome: A Review

Marilyn Hagan et al. Molecules. .

Abstract

(Poly)phenols (PPs) may have a therapeutic benefit in gastrointestinal (GI) disorders, such as irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD). The aim of this review is to summarise the evidence-base in this regard. Observational evidence does not give a clear indication that PP intake has a preventative role for IBD or IBS, while interventional studies suggest these compounds may confer symptomatic and health-related quality of life improvements in known patients. There are inconsistent results for effects on markers of inflammation, but there are promising reports of endoscopic improvement. Work on the effects of PPs on intestinal permeability and oxidative stress is limited and therefore conclusions cannot be formed. Future work on the use of PPs in IBD and IBS will strengthen the understanding of clinical and mechanistic effects.

Keywords: (poly)phenols; Crohn’s disease; inflammatory bowels disease (IBD); irritable bowel syndrome (IBS); ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) flow diagram for identification of relevant included and excluded studies.
See this image and copyright information in PMC

References

    1. Del Rio D., Rodriguez-Mateos A., Spencer J.P.E., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signal. 2013;18:1818–1892. doi: 10.1089/ars.2012.4581. - DOI - PMC - PubMed
    1. Rodriguez-Mateos A., Vauzour D., Krueger C.G., Shanmuganayagam D., Reed J., Calani L., Mena P., Del Rio D., Crozier A. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: An update. Arch. Toxicol. 2014;88:1803–1853. doi: 10.1007/s00204-014-1330-7. - DOI - PubMed
    1. Neveu V., Perez-Jiménez J., Vos F., Crespy V., du Chaffaut L., Mennen L., Knox C., Eisner R., Cruz J., Wishart D., et al. Phenol-Explorer: An online comprehensive database on polyphenol contents in foods. Database. 2010;2010 doi: 10.1093/database/bap024. - DOI - PMC - PubMed
    1. Ziauddeen N., Rosi A., Del Rio D., Amoutzopoulos B., Nicholson S., Page P., Scazzina F., Brighenti F., Ray S., Mena P. Dietary intake of (poly)phenols in children and adults: Cross-sectional analysis of UK National Diet and Nutrition Survey Rolling Programme (2008–2014) Eur. J. Nutr. 2019;58:3183–3198. doi: 10.1007/s00394-018-1862-3. - DOI - PubMed
    1. Rolfe V., Mackonochie M., Mills S., MacLennan E. Turmeric/curcumin and health outcomes: A meta-review of systematic reviews. Eur. J. Integr. Med. 2020;40:101252. doi: 10.1016/j.eujim.2020.101252. - DOI

MeSH terms

LinkOut - more resources